Trilogy Capital Inc. Abbott Laboratories Transaction History
Trilogy Capital Inc.
- $2.04 Billion
- Q2 2025
A detailed history of Trilogy Capital Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Trilogy Capital Inc. holds 4,849 shares of ABT stock, worth $651,075. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,849
Previous 2,488
94.9%
Holding current value
$651,075
Previous $330,000
99.7%
% of portfolio
0.03%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding ABT
# of Institutions
3,600Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$23.2 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.5 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$8.07 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.61 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $235B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...